ADJUVITE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ADALIMUMAB IN JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS

被引：2
|
作者：
Quartier, P. [1 ]
Despert, V. [2 ]
Poignant, S. [3 ]
Elie, C. [4 ]
Kone-Paut, I. [5 ]
Belot, A. [6 ]
Kodjikian, L. [7 ]
Monnet, D. [8 ]
Weber, M. [9 ]
Bodaghi, B. [10 ]
Baptiste, A. [4 ]
机构：
[1] Hop Necker Enfants Malad, Pediat Immunol Hematol & Rheumatol Unit, Paris, France
[2] CHU, Pediat, Rennes, France
[3] CHU, Pediat, Nantes, France
[4] Hop Necker Enfants Malad, Clin Res Unit, Paris, France
[5] CHU, Pediat, Le Kremlin Bicetre, France
[6] CHU, Pediat, Lyon, France
[7] CHU, Ophtalmol, Lyon, France
[8] Cochin Hosp, Ophtalmol, Paris, France
[9] CHU, Ophtalmol, Nantes, France
[10] Hop La Pitie Salpetriere, Ophtalmol, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0235
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [1] ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
    Quartier, Pierre
    Baptiste, Amandine
    Despert, Veronique
    Allain-Launay, Emma
    Kone-Paut, Isabelle
    Belot, Alexandre
    Kodjikian, Laurent
    Monnet, Dominique
    Weber, Michel
    Elie, Caroline
    Bodaghi, Bahram
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (07) : 1003 - 1011
  • [2] Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
    Ilowite, Norman T.
    Prather, Kristi
    Lokhnygina, Yuliya
    Schanberg, Laura E.
    Elder, Melissa
    Milojevic, Diana
    Verbsky, James W.
    Spalding, Steven J.
    Kimura, Yukiko
    Imundo, Lisa F.
    Punaro, Marilynn G.
    Sherry, David D.
    Tarvin, Stacey E.
    Zemel, Lawrence S.
    Birmingham, James D.
    Gottlieb, Beth S.
    Miller, Michael L.
    O'Neil, Kathleen
    Ruth, Natasha M.
    Wallace, Carol A.
    Singer, Nora G.
    Sandborg, Christy I.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) : 2570 - 2579
  • [3] A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
    Smith, JA
    Thompson, DJS
    Whitcup, SM
    Suhler, E
    Clarke, G
    Smith, S
    Robinson, M
    Kim, J
    Barron, KS
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (01): : 18 - 23
  • [4] Abatacept in children with juvenile idiopathic arthritis:: a randomised, double-blind, placebo-controlled withdrawal trial
    Ruperto, Nicolino
    Lovell, Daniel J.
    Quartier, Pierre
    Paz, Eliana
    Rubio-Perez, Nadina
    Silva, Clovis A.
    Abud-Mendoza, Carlos
    Burgos-Vargas, Ruben
    Gerloni, Valeria
    Melo-Gomes, Jose A.
    Saad-Magalhaes, Claudia
    Sztajnbok, Flavio
    Goldenstein-Schainberg, Claudia
    Scheinberg, Morton
    Calvo Penades, Immaculada
    Fischbach, Michael
    Orozco, Javier
    Hashkes, Philip J.
    Hom, Christine
    Jung, Lawrence
    Lepore, Loredana
    Oliveira, Sheila
    Wallace, Carol A.
    Sigal, Leonard H.
    Block, Alon J.
    Covucci, Allison
    Martini, Alberto
    Giannini, Edward H.
    LANCET, 2008, 372 (9636): : 383 - 391
  • [5] A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
    Miller, I.
    Lynggaard, C. D.
    Lophaven, S.
    Zachariae, C.
    Dufour, D. N.
    Jemec, G. B. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 391 - 398
  • [6] A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis
    Pariser, Robert J.
    Paul, Joan
    Hirano, Stefanie
    Torosky, Cyndi
    Smith, Molly
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (05) : 765 - 773
  • [7] Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
    Ruperto, Nicolino
    Brunner, Hermine, I
    Synoverska, Olga
    Ting, Tracy, V
    Mendoza, Carlos Abud
    Spindler, Alberto
    Vyzhga, Yulia
    Marzan, Katherine
    Grebenkina, Lyudmila
    Tirosh, Irit
    Imundo, Lisa
    Jerath, Rita
    Kingsbury, Daniel J.
    Sozeri, Betul
    Vora, Sheetal S.
    Prahalad, Sampath
    Zholobova, Elena
    Aviel, Yonatan Butbul
    Chasnyk, Vyacheslav
    Lerman, Melissa
    Nanda, Kabita
    Schmeling, Heinrike
    Tory, Heather
    Uziel, Yosef
    Viola, Diego O.
    Posner, Holly B.
    Kanik, Keith S.
    Wouters, Ann
    Chang, Cheng
    Zhang, Richard
    Lazariciu, Irina
    Hsu, Ming-Ann
    Suehiro, Ricardo M.
    Martini, Alberto
    Lovell, Daniel J.
    LANCET, 2021, 398 (10315): : 1984 - 1996
  • [8] Adalimumab in Severe and Acute Sciatica A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Genevay, Stephane
    Viatte, Sebastien
    Finckh, Axel
    Zufferey, Pascal
    Balague, Federico
    Gabay, Cem
    ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2339 - 2346
  • [9] Comment on 'A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis'
    Sauder, Maxwell B.
    Beecker, Jennifer
    Ramsay, Timothy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : 950 - 951
  • [10] Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
    Vena, Gino A.
    Cassano, Nicoletta
    Colombo, Delia
    Pcruzzi, Elena
    Pigatto, Paolo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 705 - 709
12345